Page 40 of 111
Previous Page     Next Page        Smaller fonts | Larger fonts     Go back to the flash version

40

nanotimes

Companies Facts

Moreover, Kopin announced financial results for the second quarter ended June 25, 2011. Total reve- nues increased 4% to $31.4 million from $30.2 million for the same quarter of last year. III-V reve- nue increased to $16.0 million, compared with $15.9 million in the second quarter of 2010. Dis- play revenue increased to $15.4 million from $14.3 million for the same quarter last year. Gross margin increased to $10.5 million, or 35% of product reve- nues, compared with $7.3 million, or 25% of product revenues, for the comparable period of 2010.

Operating expenses were $31.0 million in the se- cond quarter of 2011, compared with $30.9 million in the second quarter of 2010. R&D expenses were $7.1 million, or 23% of revenues, compared with $4.9 million, or 16 percent of revenues, in the se- cond quarter of 2010, reflecting Kopin’s investments in its Golden-i technology, III-V smartphone products and capacity expansion, military display products, and the inclusion of Forth Dimension Display’s (FDD) expenses. Selling, general and administration (S,G&A) expenses were $4.7 million in the second quarter of 2011, compared with $4.2 million for the same period of last year. The increase in S,G&A expenses is attributable to the inclusion of FDD’s expenses.

Net income was $0.8 million, or $0.01 per diluted share, for the second quarter of 2011 compared with $1.9 million, or $0.03 per diluted share, for the second quarter of 2010. Net income for the second quarter of 2010 included a $1.9 million gain from the sale of investments and a $0.7 million gain related to foreign currency fluctuations. Kopin’s 2011 second quarter results included a net gain of $0.4 million from the sale of investments and a net loss of

$0.3 million from foreign currency fluctuations.

Kopin’s cash and marketable securities balance at the end of the second quarter was $99.3 million and no long-term debt.

“With revenues for the first six months of 2011 at $66 million and the third and fourth quarters traditi- onally our strongest, we are on course to achieve our full-year revenue guidance of $130 million to $140 million,” Kopin President and Chief Executive Officer Dr. John C.C. Fan said. “Robust smartphone demand should continue to fuel our III-V business, just as the TWS-IIB and a number of military R&D programs are expected to generate momentum for our display unit.”

http://www.kopin.com M

agForce Nanotechnologies AG (FSE:MF6), announced that the Charité-Universitätsme-

dizin Berlin published the establishment of its Nano- Therm®

therapy center for the treatment of recurrent

brain tumors on: http://www.charite.de/en/charite/press/press_reports/ar-

tikel/detail/charite_etabliert_nanothermR_therapie_bei_ru- eckfaellen_von_gehirntumoren/

“I am pleased that we have accomplished this first step in making NanoTherm®

therapy available to

brain tumor patients,” said Dr. Peter Heinrich, CEO of MagForce. “There have been many challenges associated with introducing a completely new thera- peutic approach to the medical community; therefo- re, the initial rollout has taken longer than expected.

11-06/07 :: June/July 2011

Previous arrowPrevious Page     Next PageNext arrow        Smaller fonts | Larger fonts     Go back to the flash version
1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  |  9  |  10  |  11  |  12  |  13  |  14  |  15  |  16  |  17  |  18  |  19  |  20  |  21  |  22  |  23  |  24  |  25  |  26  |  27  |  28  |  29  |  30  |  31  |  32  |  33  |  34  |  35  |  36  |  37  |  38  |  39  |  40  |  41  |  42  |  43  |  44  |  45  |  46  |  47  |  48  |  49  |  50  |  51  |  52  |  53  |  54  |  55  |  56  |  57  |  58  |  59  |  60  |  61  |  62  |  63  |  64  |  65  |  66  |  67  |  68  |  69  |  70  |  71  |  72  |  73  |  74  |  75  |  76  |  77  |  78  |  79  |  80  |  81  |  82  |  83  |  84  |  85  |  86  |  87  |  88  |  89  |  90  |  91  |  92  |  93  |  94  |  95  |  96  |  97  |  98  |  99  |  100  |  101  |  102  |  103  |  104  |  105  |  106  |  107  |  108  |  109  |  110  |  111